Compare BOLT & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOLT | MTR |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 9.7M |
| IPO Year | 2021 | N/A |
| Metric | BOLT | MTR |
|---|---|---|
| Price | $4.38 | $5.09 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 15.6K | ★ 30.5K |
| Earning Date | 03-12-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 4.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,695,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $56.43 | N/A |
| P/E Ratio | ★ N/A | $22.60 |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $0.26 | $4.03 |
| 52 Week High | $7.35 | $10.42 |
| Indicator | BOLT | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 51.44 |
| Support Level | $4.42 | $4.93 |
| Resistance Level | $5.01 | $5.32 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 59.89 | 38.38 |
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.